SCHEMBL320554

SCHEMBL320554

[Li]C1C=Cc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.41
HTR6 P50406 1/20 0.40
SIGMAR1 Q99720 6/20 0.33
KDM4E B2RXH2 3/20 0.33
CYP2D6 P10635 2/20 0.33
TP53 P04637 2/20 0.33
CYP3A4 P08684 2/20 0.33
HSD17B10 Q99714 2/20 0.33
BRD4 O60885 1/20 0.33
CCL2 P13500 1/20 0.33
LMNA P02545 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
NFKB1 P19838 1/20 0.33
CHRM3 P20309 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357763 1.00 HTR2A (0.41) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL20564401 0.93 HTR2A (0.38) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL31318310 0.76 ALDH1A1 (0.33) CYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL29531714 0.75 HTR2A (0.41) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL5698322 0.74 HTR2A (0.44) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL4923162 0.73 HTR2A (0.40) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL31046607 0.72 HTR2A (0.43) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL6233907 0.72 HTR2A (0.43) HTR2AHTR6SIGMAR1KDM4ECYP2D6
Carbon Monoxide SCHEMBL4154235 0.71 HTR2A (0.39) HTR2AHTR6SIGMAR1KDM4ECYP2D6
SCHEMBL23071395 0.70 HTR2A (0.41) HTR2AHTR6SIGMAR1KDM4ECYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 433 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112382749-B Lithium ion battery anode material and preparation method thereof 华中科技大学 2024-04-12 CN claimed
CN-115117469-A Alkali metal fluoride/carbon composite material and preparation and application thereof 华中科技大学 2022-09-27 CN claimed
CN-113764762-A Method for synthesizing high-performance lithium ion battery anode material by using waste lithium ion battery 华中科技大学 2021-12-07 CN claimed
CN-112382749-A Lithium ion battery anode material and preparation method thereof 华中科技大学 2021-02-19 CN claimed
CN-112271349-A Method for recycling lithium ion positive electrode and recycled lithium ion positive electrode material 华中科技大学 2021-01-26 CN claimed
CN-112271290-A Method for preparing lithium-containing titanium niobate (LTNO) material or negative electrode and application 华中科技大学 2021-01-26 CN claimed
EP-1263764-B1 METHOD OF PREPARING GROUP 14 BRIDGED BISCYCLOPENTADIENYL LIGANDS EXXONMOBIL CHEM PATENTS INC (US) 2004-04-14 EP claimed
EP-0880549-A2 CATALYST SYSTEM AND COMPONENTS EXXON CHEMICAL PATENTS INC. (US) 1998-12-02 EP claimed
WO-1997030096-A2 CATALYST SYSTEM AND COMPONENTS EXXON CHEMICAL PATENTS INC. (US) 1997-08-21 WO claimed
EP-0475495-B1 Melt metalation of block copolymers SHELL INT RESEARCH (NL) 1995-07-05 EP claimed
EP-0475495-A2 Melt metalation of block copolymers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1992-03-18 EP claimed
US-20250326776-A1 ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2025-10-23 US disclosed
US-20250257084-A1 ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2025-08-14 US disclosed
US-12275751-B2 Organometallic complex, olefin polymerization catalyst system and polymerization process NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2025-04-15 US disclosed
EP-4496798-A1 ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS Nova Chemicals (International) S.A. (CH) 2025-01-29 EP disclosed
EP-0001547-B1 PROCESS FOR PREPARING ORGANO-NITROGEN GRAFTED COPOLYMERS, THE COPOLYMERS SO PRODUCED AND MINERAL OIL COMPOSITIONS CONTAINING THEM PHILLIPS PETROLEUM COMPANY (US) 1981-07-08 EP disclosed
EP-0024734-A2 Nitrogen-containing organic compound grafted copolymer, hydrocarbon fuel compositions, additive concentrate, and use of said copolymer in fuels PHILLIPS PETROLEUM COMPANY (US) 1981-03-11 EP disclosed
US-4238202-A NITROGEN-CONTAINING ORGANIC COMPOUND-GRAFTED, HYDROGENATED CONJUGATED DIENE-MONOVINYLARENE COPOLYMER PHILLIPS PETROLEUM COMPANY (US) 1980-12-09 US disclosed
EP-0001547-A1 Process for preparing organo-nitrogen grafted copolymers, the copolymers so produced and mineral oil compositions containing them PHILLIPS PETROLEUM COMPANY (US) 1979-05-02 EP disclosed
US-4145298-A HYDROGENATED LITHIATED COPOLYMERS GRAFTED WITH ORGANIC NITROGEN COMPOUNDS AS VISCOSITY INDEX IMPROVERS HAVING DISPERSANT PROPERTIES PHILLIPS PETROLEUM COMPANY (US) 1979-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12275751-B2 Organometallic complex, olefin polymerization catalyst system and polymerization process CYC1, CYP4F12, COASY HTR2A 4502/4885HTR6 4150/4885SIGMAR1 1836/4885
US-20250257084-A1 ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS CYC1, CYP4F12, COASY HTR2A 4502/4885HTR6 4150/4885SIGMAR1 1836/4885
US-20250326776-A1 ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS LIG1, C1S, ALOX12 HTR2A 4251/4885HTR6 4014/4885SIGMAR1 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.